MYX 1.06% $4.68 mayne pharma group limited

Ann: 2013 Full Year Results Investor Presentation, page-2

  1. 16,270 Posts.
    lightbulb Created with Sketch. 399
    re: Ann: 2013 Full Year Results Investor Pres... The financials look OK although profit was lower due to acquisition costs. Sales and revenue continue to increase. Obviously from the share price reaction this outcome was already factored in.

    Long term play!

    H
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.